On this page
Thomas D. Carey
Insider
First SEC filing: June 23, 2026 · Latest: June 23, 2026
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net: $0
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| June 18, 2026 | LAB | A | 263,884 | · | · | 263,884 Direct | · | Acquired | (price as of 2026-10-05) |
| June 18, 2026 | LAB | A | 99,116 | · | · | 344,456 Direct | +40.40% | Acquired | (price as of 2026-10-05) |
| Feb. 26, 2026 | LAB | A | 51,282 | $1.17 | $60,000 | 245,340 Direct | +26.43% | Acquired | -34.8% (price as of 2026-10-05) |
| June 20, 2025 | LAB | A | 188,490 | · | · | 188,490 Direct | · | Acquired | (price as of 2026-10-05) |
| June 20, 2025 | LAB | A | 94,592 | · | · | 194,058 Direct | +95.10% | Acquired | (price as of 2026-10-05) |
| Feb. 28, 2025 | LAB | A | 56,338 | $1.06 | $59,718 | 99,466 Direct | +130.63% | Acquired | -28.0% (price as of 2026-10-05) |
| June 28, 2024 | LAB | A | 108,319 | · | · | 108,319 Direct | · | Acquired | (price as of 2026-10-05) |
| June 28, 2024 | LAB | A | 43,128 | · | · | 43,128 Direct | · | Acquired | (price as of 2026-10-05) |
| Jan. 5, 2024 | LAB | A | 205,794 | · | · | 205,794 Direct | · | Acquired | (price as of 2026-10-05) |
| Jan. 5, 2024 | LAB | A | 79,412 | · | · | 79,412 Direct | · | Acquired | (price as of 2026-10-05) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| June 18, 2026 | LAB | Stock Option (Right to buy) | Common Stock | $0.83 | June 18, 2036 | 263,884 | Acquired |
| June 20, 2025 | LAB | Stock Option (Right to buy) | Common Stock | $1.05 | June 20, 2035 | 188,490 | Acquired |
| June 28, 2024 | LAB | Stock Option (Right to buy) | Common Stock | $1.77 | June 28, 2034 | 108,319 | Acquired |
| Jan. 5, 2024 | LAB | Stock Option (Right to buy) | Common Stock | $2.47 | June 7, 2033 | 205,794 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).